FR2552776B1 - VECTORS FOR THE EXPRESSION OF AN ANTIGENIC PROTEIN OF RABIES IN EUKARYOTIC CELLS AND THEIR APPLICATION TO THE PREPARATION OF A VACCINE - Google Patents

VECTORS FOR THE EXPRESSION OF AN ANTIGENIC PROTEIN OF RABIES IN EUKARYOTIC CELLS AND THEIR APPLICATION TO THE PREPARATION OF A VACCINE

Info

Publication number
FR2552776B1
FR2552776B1 FR8315716A FR8315716A FR2552776B1 FR 2552776 B1 FR2552776 B1 FR 2552776B1 FR 8315716 A FR8315716 A FR 8315716A FR 8315716 A FR8315716 A FR 8315716A FR 2552776 B1 FR2552776 B1 FR 2552776B1
Authority
FR
France
Prior art keywords
rabies
vaccine
vectors
expression
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8315716A
Other languages
French (fr)
Other versions
FR2552776A1 (en
Inventor
Richard Lathe
Marie Paule Kieny
Yves Lemoine
Gerard Loison
Michel Aigle
Jean Pierre Lecocq
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Transgene SA
Original Assignee
Transgene SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene SA filed Critical Transgene SA
Priority to FR8315716A priority Critical patent/FR2552776B1/en
Priority to PCT/FR1984/000217 priority patent/WO1985001516A1/en
Priority to EP84401962A priority patent/EP0140762A1/en
Priority to JP59503639A priority patent/JPS61500946A/en
Publication of FR2552776A1 publication Critical patent/FR2552776A1/en
Priority to DK250085A priority patent/DK250085A/en
Application granted granted Critical
Publication of FR2552776B1 publication Critical patent/FR2552776B1/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/78—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Pseudomonas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/20043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/22011—Polyomaviridae, e.g. polyoma, SV40, JC
    • C12N2710/22041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/22043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FR8315716A 1983-10-03 1983-10-03 VECTORS FOR THE EXPRESSION OF AN ANTIGENIC PROTEIN OF RABIES IN EUKARYOTIC CELLS AND THEIR APPLICATION TO THE PREPARATION OF A VACCINE Expired FR2552776B1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR8315716A FR2552776B1 (en) 1983-10-03 1983-10-03 VECTORS FOR THE EXPRESSION OF AN ANTIGENIC PROTEIN OF RABIES IN EUKARYOTIC CELLS AND THEIR APPLICATION TO THE PREPARATION OF A VACCINE
PCT/FR1984/000217 WO1985001516A1 (en) 1983-10-03 1984-10-02 Vectors for the expression of an antigenic protein of rabies in eucaryotic cells and application thereof to the preparation of a vaccine
EP84401962A EP0140762A1 (en) 1983-10-03 1984-10-02 Vectors for the expression of an antigenic rabies protein in eukaryotic cells, and their use in the preparation of a vaccine
JP59503639A JPS61500946A (en) 1983-10-03 1984-10-02 Vector for expressing rabies antigenic protein in eukaryotic cells and its application to vaccine production
DK250085A DK250085A (en) 1983-10-03 1985-06-03 VECTORS FOR ANTIGEN EXPRESSION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8315716A FR2552776B1 (en) 1983-10-03 1983-10-03 VECTORS FOR THE EXPRESSION OF AN ANTIGENIC PROTEIN OF RABIES IN EUKARYOTIC CELLS AND THEIR APPLICATION TO THE PREPARATION OF A VACCINE

Publications (2)

Publication Number Publication Date
FR2552776A1 FR2552776A1 (en) 1985-04-05
FR2552776B1 true FR2552776B1 (en) 1986-05-09

Family

ID=9292754

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8315716A Expired FR2552776B1 (en) 1983-10-03 1983-10-03 VECTORS FOR THE EXPRESSION OF AN ANTIGENIC PROTEIN OF RABIES IN EUKARYOTIC CELLS AND THEIR APPLICATION TO THE PREPARATION OF A VACCINE

Country Status (2)

Country Link
JP (1) JPS61500946A (en)
FR (1) FR2552776B1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830477A (en) * 1984-04-25 1998-11-03 Transgene S.A. Vaccine against rabies and process for preparation thereof
FR2563434B1 (en) * 1984-04-25 1986-07-25 Transgene Sa Rabies vaccine and process for its preparation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ199722A (en) * 1981-02-25 1985-12-13 Genentech Inc Dna transfer vector for expression of exogenous polypeptide in yeast;transformed yeast strain
DK368882A (en) * 1981-08-25 1983-02-26 Alan John Kingsman EXPESSIONS VECTORS
ZW18282A1 (en) * 1981-08-31 1983-03-23 Genentech Inc Preparation of polypeptides in vertebrate cell culture
US4393201A (en) * 1981-11-04 1983-07-12 The Wistar Institute DNA Which codes for glycoprotein of era-strain rabies virus
US4446235A (en) * 1982-03-22 1984-05-01 Genentech, Inc. Method for cloning human growth hormone varient genes

Also Published As

Publication number Publication date
JPS61500946A (en) 1986-05-15
FR2552776A1 (en) 1985-04-05

Similar Documents

Publication Publication Date Title
AU3393993A (en) Method of administering proteins to living skin cells
FR2586587B1 (en) NEW ARTIFICIAL SURFACTANTS, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
ITTO910001A1 (en) IMPROVED METHOD TO PRODUCE COFFEE EXTRACTS
DK40591D0 (en) THREE-DIMENSIONAL CELL AND TISSUE CULTURE SYSTEM
NL930132I1 (en) Vaccine against hepatitis B virus method and transformed eukaryotic cells and the preparation of that vaccine
IT1178588B (en) HYALURONIC ACID PREPARATIONS INSOLUBLE IN WATER AND PROCEDURE TO PREPARE THEM
JPS539762A (en) Hydoxyysuccinimideeester derivative* its preparation and method of bonding biologically active proteins
BE891797A (en) NOVEL DERIVATIVES OF FURO- (3,4-C) -PYRIDINE, THEIR PREPARATION AND THEIR THERAPEUTIC USE
BE861857A (en) PREPARATION OF NUCLEIC ACIDS, CELL DIALYSIS PRODUCTS AND SPECIFIC IMMUNE ANTIBODIES
FR2577139B1 (en) VACCINE COMPOSITION AND METHOD OF PREPARATION
IT8768027A0 (en) DERIVATIVES OF 1 PIPERAZINIL PYRIMIDINE THEIR PREPARATION AND USE IN THERAPY AND COSMETICS
FI881743A0 (en) Method for the preparation of bifunctional proteins
DE69110877D1 (en) IDIOTYPE Vaccination Against B-CELL LYMPHOMA.
IT1191732B (en) METHOD TO JOIN THE ENDS OF TWO ELONGATED ELEMENTS PROVIDED WITH PERIPHERAL GROOVES AND JUNCTION SO OBTAINED
LU79477A1 (en) METHODS FOR PREPARING THE ANTIGEN OF THE HEPATITIS B CORE AND VACCINES CONTAINING IT
DK230288A (en) PHARMACEUTICAL PREPARATIONS IN THE FORM OF SMALL PEARLS AND PROCEDURE FOR THEIR PREPARATION
KR890700662A (en) Viral antigens and methods for their preparation and methods of use for diagnostic and therapeutic purposes
IT1215478B (en) IMPROVED EXPRESSION OF HUMAN INTERLEUCHINA-2 IN MAMMAL CELLS.
IT1115787B (en) IMPROVEMENT IN ANTI-ACIDITY PREPARATIONS IN THE FORM OF TABS
IT1121914B (en) PROCEDURE FOR THE PREPARATION OF UROKINASE IN THE PURE STATE
MA20068A1 (en) New flavone-carboxylic-4 acids; their method of preparation and their therapeutic application.
FR2552776B1 (en) VECTORS FOR THE EXPRESSION OF AN ANTIGENIC PROTEIN OF RABIES IN EUKARYOTIC CELLS AND THEIR APPLICATION TO THE PREPARATION OF A VACCINE
DK20587D0 (en) COSMETIC AGENTS WITH SKIN COSMETIC AND SKIN GENERATING EFFECT AND PROCEDURE FOR THEIR PREPARATION
FR2600334B1 (en) VECTORS FOR INTEGRATION INTO EUKARYOTIC CELLS PROVIDING EXPRESSION OF FACTOR IX, CELULLAR LINES OBTAINED AND PROCESS FOR THEIR PREPARATION
FR2571060B1 (en) NOVEL CLONING AND EXPRESSION VECTORS IN EUKARYOTIC CELLS USING THE VACCINE VIRUS

Legal Events

Date Code Title Description
ST Notification of lapse